MolecularCanvas: LLM-assisted Small-Molecule Drug Discovery via Structure-Guided Constraints

Small-molecule drug discovery relies on iterative molecular optimization, where chemists repeatedly modify candidate compounds to balance multiple competing properties such as efficacy, toxicity, and solubility. Recent advances in generative AI (GenAI) have shown promise in accelerating this process by automatically proposing new molecular structures or targeted modifications. However, existing GenAI-based molecular design tools remain poorly aligned with experts' real-world workflows. Specifically, they offer limited support for specifying structure-level modification intents on molecules, provide insufficient transparency into model-generated modifications, and lack integrated support for downstream property evaluation with external computational tools. To address these challenges, we introduce MolecularCanvas, an interactive system that enables users to iteratively construct an optimization context by integrating high-level goals, structure-level annotations, property constraints, and reference-based preferences. This context guides the generation of candidate molecules across diverse molecular structures. MolecularCanvas further enhances transparency by providing evidence for AI-generated suggestions and streamlines molecular evaluation by integrating commonly used computational tools for property assessment into a unified interface. Finally, a user study with 12 participants demonstrates the usefulness and effectiveness of MolecularCanvas in helping users optimize candidate molecules.

Source: arXiv:2608.00393v1 - http://arxiv.org/abs/2608.00393v1 PDF: https://arxiv.org/pdf/2608.00393v1 Original Link: http://arxiv.org/abs/2608.00393v1